Anticancer drug development and federal regulation: Protection against progress?
- 30 September 1981
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 71 (3) , 341-344
- https://doi.org/10.1016/0002-9343(81)90147-9
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- New Ethical-Review Policy for Clinical Medical ResearchNew England Journal of Medicine, 1981
- Development of new drugs originated and acquired by United States–owned pharmaceutical firms, 1963-1976*Clinical Pharmacology & Therapeutics, 1980
- The drug lag revisited: Comparison by therapeutic area of patterns of drugs marketed in the United States and Great Britain from 1972 through 1976Clinical Pharmacology & Therapeutics, 1978
- Profitable and Nonprofitable DrugsNew England Journal of Medicine, 1978
- Letter to the editorMedical and Pediatric Oncology, 1978